Table 1.
Source | Number of CFU-EPCs per 106 MNCs plated |
---|---|
Unfractioned MNCs* | 21 |
2-h adherent cells (> 80% CD14+)* | 25 |
2-h non-adherent cells* | 2 |
CD14-enriched (> 98%)* | 41 |
CD14-depleted* | 0 |
CD34-enriched (> 90%)† | 0 |
CD34-depleted† | 3 |
CD133-enriched (> 90%)† | 0 |
CD133-depleted† | 8 |
CFU-EPCs are slightly increased when normal peripheral blood MNCs are enriched for monocytes (to about 80% CD14+) by 2 h of adherence on uncoated culture plates. Further enrichment of monocytes (to 98%) by CD14+ selection by fluorescence-activated cell sorting further increased CFU-EPCs and completely removed CFU-EPCs from the CD14-depleted plastic-adherent cells. CFU-EPCs were not found in CD34-enriched (> 90%) or CD133-enriched (> 90%) MNCs from different HPC-rich cell sources. Their depleted column eluates tend to show reduced CFU-EPC activity as compared with the unfractioned starting MNCs, which may imply some loss of CFU-EPC activity by retention on columns by adhesion, implying these cells are adherent.
Paired normal peripheral blood samples (n = 6).
Unpaired HPC-rich samples (bone marrow, cord blood, mobilized blood).